🔹 Product Overview
Nubieexa 40 mg Tablet is a prescription anti-cancer medicine used in the treatment of certain advanced cancers.
Contains Regorafenib 40 mg, a multi-kinase inhibitor that helps slow the growth and spread of cancer cells.
Commonly prescribed for patients with specific cancers that have progressed despite prior treatment.
🔹 Key Uses
Treatment of metastatic colorectal cancer
Management of gastrointestinal stromal tumors (GIST)
Treatment of hepatocellular carcinoma (liver cancer) after prior therapy failure
Helps slow cancer progression and tumor growth
🔹 Composition
Active ingredient: Regorafenib 40 mg
Belongs to the tyrosine kinase inhibitor class
Used in targeted cancer therapy
🔹 How It Works
Blocks multiple protein kinases involved in tumor growth
Inhibits formation of new blood vessels that supply tumors
Helps slow the growth and spread of cancer cells throughout the body
🔹 Key Benefits
Effective targeted cancer treatment
Helps control progression of advanced cancers
Supports long-term cancer management under specialist supervision
May improve disease control in patients who have received previous therapies
🔹 Dosage and Administration
Take exactly as prescribed by an oncologist
Usually taken once daily during a treatment cycle
Swallow whole with water after a low-fat meal
Do not alter the dose without medical advice
🔹 Possible Side Effects
Fatigue and weakness
Diarrhea
Loss of appetite
Nausea
High blood pressure
Hand-foot skin reactions
Weight loss
🔹 Precautions
Use only under specialist medical supervision
Regular monitoring of liver function and blood pressure is required
Inform your doctor about heart, liver, or kidney conditions
Avoid pregnancy during treatment
Report unusual bleeding, severe skin reactions, or persistent diarrhea immediately
Important: Always follow your healthcare provider's instructions when using this medication.
Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.
Hello! How can we help you today?
Our pharmaceutical experts typically reply in a few minutes.
Start Chat